Alzheimer’s Drug Discovery Foundation Supports ADispell Technology With A Grant To Advance Novel Drug Candidates For …

Tuesday, March 22nd, 2011

The Alzheimer’s Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $170,750 to ADispell Inc. to develop small molecule drugs designed to halt the progression of cognition loss that occurs with Alzheimer’s Disease.

Read the original:
... continue reading

Posted in Alzheimer's Disease | No Comments »

Alzheimer’s Drug Discovery Foundation Funds AgeneBio To Advance Pharmacological Neural Stabilizer Technology

Saturday, August 28th, 2010

The Alzheimer’s Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer’s disease and affects more than 3 million ... continue reading

Posted in Alzheimer's Disease | No Comments »